A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel.
Aebi S, Schnider TW, Los G, Heath DD, Darrah D, Kirmani S, McClay EF, D'Agostino H, Plaxe SC, Fink D, De las Alas MM, Howell SB, Christen RD.
Aebi S, et al. Among authors: howell sb.
Cancer Chemother Pharmacol. 1999;44(3):259-65. doi: 10.1007/s002800050976.
Cancer Chemother Pharmacol. 1999.
PMID: 10453729
Clinical Trial.